September 2021 FDA Recall Drug by Piramal Critical Care, Inc.
D-0019-2022 - Labeling

This Class II drug recall was voluntarily initiated by Piramal Critical Care, Inc. on September 10, 2021 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0019-2022

Reason for Recall
Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"
Initiated
09-10-2021
Reported
10-27-2021
Quantity
100 glass vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Piramal Critical Care, Inc.
Nationwide within the United States
Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care, Bethlehem, PA 18017, USA, Manufactured by: Sanovel Ilac, San. Ve Tic. A.S. Istanbul, Turkey, NDC 66794-0228-41

Batch or Lot Expiration Information

Lot# : 20415001, 20415002, Expiration Date 05/2022